Alicia Rodriguez

NPI: 1851345516
Total Payments
$747.04
2024 Payments
$45.71
Companies
7
Transactions
22

Payment Breakdown by Category

Food & Beverage$747.04 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $747.04 22 100.0%

Top Paying Companies

Company Total Records Latest Year
Merck Sharp & Dohme LLC $475.42 12 $0 (2024)
Teva Pharmaceuticals USA, Inc. $112.50 1 $0 (2020)
Edwards Lifesciences Corporation $47.08 2 $0 (2018)
Chiesi USA, Inc. $40.52 3 $0 (2019)
Smith+Nephew, Inc. $28.12 2 $0 (2019)
Janssen Pharmaceuticals, Inc $25.00 1 $0 (2024)
E.R. Squibb & Sons, L.L.C. $18.40 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $45.71 2 Janssen Pharmaceuticals, Inc ($25.00)
2023 $17.37 1 Merck Sharp & Dohme LLC ($17.37)
2022 $31.26 2 Merck Sharp & Dohme LLC ($31.26)
2021 $14.45 1 Merck Sharp & Dohme Corporation ($14.45)
2020 $125.34 2 Teva Pharmaceuticals USA, Inc. ($112.50)
2019 $26.08 2 Chiesi USA, Inc. ($13.51)
2018 $285.79 8 Merck Sharp & Dohme Corporation ($206.46)
2017 $201.04 4 Merck Sharp & Dohme Corporation ($172.33)

All Payment Transactions

22 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
09/18/2024 Merck Sharp & Dohme LLC BRIDION (Drug), RECARBRIO, ZERBAXA Food and Beverage In-kind items and services $20.71 General
Category: NEUROSCIENCE
04/24/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $25.00 General
Category: Cardiovascular & Metabolism
05/31/2023 Merck Sharp & Dohme LLC ZERBAXA (Drug), RECARBRIO Food and Beverage In-kind items and services $17.37 General
Category: INFECTIOUS DISEASE
11/23/2022 Merck Sharp & Dohme LLC BRIDION (Drug), ZERBAXA Food and Beverage In-kind items and services $17.37 General
Category: NEUROSCIENCE
02/16/2022 Merck Sharp & Dohme LLC ZERBAXA (Drug), RECARBRIO Food and Beverage In-kind items and services $13.89 General
Category: INFECTIOUS DISEASE
07/07/2021 Merck Sharp & Dohme Corporation RECARBRIO (Drug) Food and Beverage In-kind items and services $14.45 General
Category: INFECTIOUS DISEASE
10/07/2020 Merck Sharp & Dohme Corporation ZERBAXA (Drug), RECARBRIO Food and Beverage In-kind items and services $12.84 General
Category: INFECTIOUS DISEASE
02/25/2020 Teva Pharmaceuticals USA, Inc. AJOVY (Biological) Food and Beverage In-kind items and services $112.50 General
Category: Central Nervous System
12/19/2019 Smith+Nephew, Inc. Food and Beverage In-kind items and services $12.57 General
09/25/2019 Chiesi USA, Inc. CLEVIPREX (Drug) Food and Beverage Cash or cash equivalent $13.51 General
Category: CARDIOVASCULAR
12/19/2018 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $18.40 General
Category: Cardiovascular
11/27/2018 Merck Sharp & Dohme Corporation ZERBAXA (Drug) Food and Beverage In-kind items and services $100.00 General
Category: INFECTIOUS DISEASE
10/31/2018 Chiesi USA, Inc. CLEVIPREX (Drug) Food and Beverage Cash or cash equivalent $13.85 General
Category: CARDIOVASCULAR
10/24/2018 Merck Sharp & Dohme Corporation INVANZ (Drug), ZERBAXA Food and Beverage In-kind items and services $8.33 General
Category: INFECTIOUS DISEASE
08/16/2018 Merck Sharp & Dohme Corporation ZERBAXA (Drug) Food and Beverage In-kind items and services $87.02 General
Category: INFECTIOUS DISEASE
05/16/2018 Merck Sharp & Dohme Corporation Food and Beverage In-kind items and services $11.11 General
02/09/2018 Edwards Lifesciences Corporation EV1000 Clinical Platform (Device) Food and Beverage In-kind items and services $28.95 General
Category: Minimally Invasive Hemodynamic Monitoring
02/08/2018 Edwards Lifesciences Corporation EV1000 Clinical Platform (Device) Food and Beverage In-kind items and services $18.13 General
Category: Minimally Invasive Hemodynamic Monitoring
09/13/2017 Chiesi USA, Inc. CLEVIPREX (Drug) Food and Beverage Cash or cash equivalent $13.16 General
Category: CARDIOVASCULAR
06/28/2017 Merck Sharp & Dohme Corporation ZERBAXA (Drug) Food and Beverage In-kind items and services $72.34 General
Category: INFECTIOUS DISEASE
03/08/2017 Smith & Nephew, Inc. PICO (Device) Food and Beverage In-kind items and services $15.55 General
Category: Negative Pressure Wound Therapy
02/23/2017 Merck Sharp & Dohme Corporation ZERBAXA (Drug) Food and Beverage In-kind items and services $99.99 General
Category: INFECTIOUS DISEASE

About Alicia Rodriguez

Alicia Rodriguez is a General Practice healthcare provider based in Bayamon, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851345516.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Alicia Rodriguez has received a total of $747.04 in payments from pharmaceutical and medical device companies, with $45.71 received in 2024. These payments were reported across 22 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($747.04).

Practice Information

  • Specialty General Practice
  • Location Bayamon, PR
  • Active Since 05/19/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 208D00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1851345516

Products in Payments

  • ZERBAXA (Drug) $403.45
  • AJOVY (Biological) $112.50
  • EV1000 Clinical Platform (Device) $47.08
  • CLEVIPREX (Drug) $40.52
  • BRIDION (Drug) $38.08
  • XARELTO (Drug) $25.00
  • ELIQUIS (Drug) $18.40
  • PICO (Device) $15.55
  • RECARBRIO (Drug) $14.45
  • INVANZ (Drug) $8.33

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

General Practice Doctors in Bayamon